Repinex XL Summary of Product Characteristics
These links will take you to the electronic Medicines Compendium (eMC) website.
Repinex XL 2mg prolonged-release tablets SmPC: View SmPC
Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard.
Adverse events should also be reported to Aspire Pharma Ltd on 01730 231148
For more information about Repinex XL, please click here for the prescribing information.